Rayence Co., Ltd. (KOSDAQ: 228850)

Market Cap	110.31B
Revenue (ttm)	136.32B
Net Income (ttm)	17.56B
Shares Out	15.74M
EPS (ttm)	1,115.60
PE Ratio	6.28
Forward PE	7.78
Dividend	100.00 (1.41%)
Ex-Dividend Date	n/a

Volume	1,022
Open	7,030.00
Previous Close	7,010.00
Day's Range	7,010.00 - 7,050.00
52-Week Range	6,950.00 - 10,180.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 227
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2023, Rayence's revenue was 142.99 billion, a decrease of -2.84% compared to the previous year's 147.16 billion. Earnings were 19.60 billion, a decrease of -11.11%.